As of 2025-10-19, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (54.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -131.7%.
The range of the Relative Valuation is (48.52) - (54.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 21.0x | 20.5x |
| Forward P/E multiples | 18.6x - 23.3x | 21.4x |
| Fair Price | (48.52) - (54.73) | (54.65) |
| Upside | -128.2% - -131.8% | -131.7% |
| Date | P/E |